Detect Sepsis Faster

VSNO™ Technology enables healthcare to save lives with innovative proprietary sepsis detection

As many as 80% of sepsis deaths could be avoided with rapid diagnosis and treatment.

VSNO™ TECHNOLOGY KEY ADVANTAGES:
Measures exhaled Nitric Oxide (NO)
Hand-held breath test
Results in minutes vs hours
Portable design for EmergencyDepartments, Ambulances, Urgent Care and beyond

How it works

measure

Measure Nitric Oxide

VSNO™ measures a patient’s exhaled Nitric Oxide (NO), a critical signaling molecule for sepsis risk.

test

Confirm Infection

Infection confirmed via NO & non-invasive tests (body temperature, heart rate, respiratory rate).

result

Rapid and Accurate Screening

Unique patented sepsis screening, completed in minutes without a blood draw.

“quote quote quote quotequote quote quote quotequote quote quote quote”

MICHAEL ZWANK, MD

VSNO™ compared to current solutions

When compared to the current non-invasive triage tests, adding Nitric Oxide (NO) to create a VSNO score improves the sepsis detection sensitivity significantly.

For conditions associated with a high mortality risk, it has been proposed that sensitivity and negative predictive values should exceed 80%. Sensitivity is important given the need to identify those patients, while high negative predictive value is important to have confidence as a rule-out measurement.

In recent clinical trials, only VSNO met the standards of high sensitivity and negative predictive value.

Clinical Trials & Milestones

Vail Scientific has completed two initial clinical trials, and is on a path to gain FDA approval.

Key Findings:

  • Statistically significant differences in NO between healthy volunteers and patients.
  • Significant improvement shown in infection detection sensitivity.
  • Sensitivity and Negative Predictive Value (NPV) met published recommendations for high-risk medical condition biomarker tests.

Rapid Sepsis Detection
Starts Now

Scroll to Top